Daré Bioscience Inc (DARE)
NASDAQ:DARE
Holding DARE?
Track your performance easily

Daré Bioscience (DARE) Financial Statements

1,799 Followers

Daré Bioscience Financial Overview

Daré Bioscience's market cap is currently ―. The company's EPS TTM is $-0.984; its P/E ratio is -3.41; Daré Bioscience is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 22.44K$ 9.30K$ 1.00M--
Gross Profit$ 22.44K$ 9.30K$ 1.00M--
EBIT$ -7.36M$ -6.73M$ -8.25M$ -8.71M$ -8.04M
EBITDA$ -7.34M$ -6.72M$ -8.24M$ -8.70M$ -8.03M
Net Income Common Stockholders$ 12.91M$ -6.80M$ -8.30M$ -8.76M$ -8.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.40M$ 3.60M$ 13.90M$ 13.30M$ 19.83M
Total Assets$ 23.61M$ 13.01M$ 25.05M$ 23.18M$ 30.37M
Total Debt$ 1.52M$ 1.64M$ 195.00K$ 295.00K$ 393.00K
Net Debt$ -14.88M$ -1.96M$ -13.71M$ -13.01M$ -19.44M
Total Liabilities$ 20.93M$ 24.01M$ 27.34M$ 25.94M$ 25.37M
Stockholders Equity$ 2.67M$ -11.00M$ -2.29M$ -2.74M$ 4.99M
Cash Flow-
Free Cash Flow$ 12.62M$ -6.82M$ -8.00M$ -6.63M$ -16.08M
Operating Cash Flow$ 12.90M$ -6.81M$ -7.97M$ -6.63M$ -16.08M
Investing Cash Flow$ -285.23K$ -7.30K$ -22.10K--
Financing Cash Flow$ 115.37K$ 14.03K$ 8.58M$ 452.19K$ 1.30M
Currency in USD

Daré Bioscience Earnings and Revenue History

Daré Bioscience Debt to Assets

Daré Bioscience Cash Flow

Daré Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis